In addition, the immunohistochemical results revealed that the staining intensity of HSP90B1 protein in patients with GBM was more pronounced than that in patients with astrocytoma or oligodendroglioma (Figures 6F, G). This evidence concerns the gene HSP90B1 and astrocytoma (excluding glioblastoma).